Clinical Trial

Italian Treatment Free Remission Registry

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 18, 2021 (before its estimated July 8, 2022 completion). Its status may not reflect the trial's current state.
Summary
The investigator propose an extension of the previous National, multicentric study, promoting an observational registry, both retrospective and prospective, in order to expand and further characterize the series of Italian patients with Philadelphia-positive, chronic phase CML (CP-CML) who discontinue TKIs in an off-protocol setting. As safety concerns may arise for patients receiving long-term treatments, and due to the growing number of patients discontinuing TKIs in clinical practice, the study aim to collect all available data regarding feasibility and freedom from progression of the cohort of patients.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2021-02-22; most recent amendment 2021-11-17.
Trial Details
NCT Number NCT04769947
Lead Sponsor University of Turin, Italy
Conditions Treatment Free Remission, Chronic Myeloid Leukemia
Enrollment 800 participants
Start Date 2021-08-09
Primary Completion 2022-07-08 (estimated)
Study Completion 2030-02-08 (estimated)
Updated on ClinicalTrials.gov 2021-11-18